Cargando…

Chronic Human Herpes Virus 8 Infection Successfully Treated With Valganciclovir

BACKGROUND: A 57 year old Italian female with a 3 year history of constituitional symptoms with non-HIV Kaposi sarcoma was referred to the immunology clinic. She was previously diagnosed with chronic human herpes virus 8 (HHV8) infection with positive HHV8 polymerase chain reaction in serum. OBJECTI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yun, James J, Preda, Veronica, Frankum, Brad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Allergy Organization 2009
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651015/ https://www.ncbi.nlm.nih.gov/pubmed/23283061 http://dx.doi.org/10.1097/WOX.0b013e3181abe7b6

Ejemplares similares

Non-healing Vulval Ulcer in an Immunocompromised Female due to Concurrent Herpes Simplex Virus and Cytomegalovirus Co-infection Treated Effectively with Valganciclovir
por: Sinha, Preema, et al.
Publicado: (2020)

Cytomegalovirus retinitis treated with valganciclovir in Wegener’s granulomatosis
por: Kabata, Yoshiaki, et al.
Publicado: (2012)

1146. Thrombocytosis in Infants with Congenital Cytomegalovirus Infection Being Treated with Valganciclovir
por: Murtagh, Kathleen, et al.
Publicado: (2020)

Assessment of mitochondrial toxicity in newborns and infants with congenital cytomegalovirus infection treated with valganciclovir
por: Ortiz-Gracia, Alba, et al.
Publicado: (2022)

Valganciclovir: Leucopenia: case report
Publicado: (2021)

Valganciclovir in the treatment of cytomegalovirus retinitis in HIV-infected patients
por: Patil, A Jayaprakash, et al.
Publicado: (2010)

Trichodysplasia spinulosa successfully treated with adapalene 0.1% gel and oral valganciclovir in a renal transplant recipient
por: Shah, Pooja R., et al.
Publicado: (2019)

Advances in Alpha Herpes Viruses Vaccines for Human
por: Preda, Madalina, et al.
Publicado: (2023)

Thrombocytopenia Secondary to Herpes Simplex Virus-2 Infection Successfully Treated by Acyclovir
por: Siddiqui, Raheel S, et al.
Publicado: (2020)

Case report: severe cytomegalovirus primary infection in an immunocompetent adult with disseminated intravascular coagulation treated with valganciclovir
por: Müller, Niklas F., et al.
Publicado: (2016)

Valganciclovir as Add-On to Standard Therapy in Secondary Glioblastoma
por: Stragliotto, Giuseppe, et al.
Publicado: (2020)

Mycophenolate-mofetil/valganciclovir: Neutropenia: case report
Publicado: (2022)

Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients
por: Doesch, Andreas O, et al.
Publicado: (2012)

Valganciclovir is not associated with decreased EBV infection rate in pediatric kidney transplantation
por: Cheyssac, Elodie, et al.
Publicado: (2023)

Role of Valganciclovir in Children with Congenital CMV Infection: A Review of the Literature
por: Pata, Davide, et al.
Publicado: (2023)

Efficacy of Extended Valganciclovir Prophylaxis in Preventing Cytomegalovirus Infection in Pediatric Kidney Transplantation
por: Hashim, Faris, et al.
Publicado: (2014)

Cytokine and Chemokine Secretome and Risk of CMV Infection Following Discontinuation of Valganciclovir Prophylaxis
por: Fernández-Ruiz, Mario, et al.
Publicado: (2023)

Development of an appropriate simple suspension method for valganciclovir medication
por: Masaoka, Yasuyuki, et al.
Publicado: (2020)

Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients
por: Johansson, Inger, et al.
Publicado: (2013)

The Association Between Cytomegalovirus Infection and Cardiac Allograft Vasculopathy in the Era of Antiviral Valganciclovir Prophylaxis
por: Klimczak-Tomaniak, Dominika, et al.
Publicado: (2019)

Long-Term Clinical, Audiological, Visual, Neurocognitive and Behavioral Outcome in Children With Symptomatic and Asymptomatic Congenital Cytomegalovirus Infection Treated With Valganciclovir
por: Turriziani Colonna, Arianna, et al.
Publicado: (2020)

Valganciclovir as Add-on to Second-Line Therapy in Patients with Recurrent Glioblastoma
por: Pantalone, Mattia Russel, et al.
Publicado: (2022)

The pharmacokinetics of valganciclovir prophylaxis in pediatric solid organ transplant patients at risk for Epstein–Barr virus disease
por: Vezina, Heather E, et al.
Publicado: (2009)

Long-term results of oral valganciclovir for treatment of anterior segment inflammation secondary to cytomegalovirus infection
por: Wong, Victoria WY, et al.
Publicado: (2012)

Efficacy of Valganciclovir Treatment Depends on the Severity of Hearing Dysfunction in Symptomatic Infants with Congenital Cytomegalovirus Infection
por: Ohyama, Shohei, et al.
Publicado: (2019)

Absence of human herpes virus-8 (HHV8) in nephrogenic systemic fibrosis
por: O'Donnell, Patrick J, et al.
Publicado: (2008)

Valganciclovir Inhibits Human Adenovirus Replication and Pathology in Permissive Immunosuppressed Female and Male Syrian Hamsters
por: Toth, Karoly, et al.
Publicado: (2015)

New algorithm for valganciclovir dosing in pediatric solid organ transplant recipients
por: Åsberg, A, et al.
Publicado: (2014)

High frequency of valganciclovir underdosing for cytomegalovirus prophylaxis after renal transplantation
por: Rissling, Olesja, et al.
Publicado: (2018)

High Throughput Screening of Valganciclovir in Acidic Microenvironments of Polyester Thin Films
por: Schaller, Teilo, et al.
Publicado: (2015)

Chronic Ulcerative Herpes Simplex Virus Infection of the Vulva
por: Griffith-Bauer, Kelly, et al.
Publicado: (2012)

Successful Confirmation of Dual Genital Herpes Co-Infection with Herpes Simplex Virus 1 and Herpes Simplex Virus 2 Using Unbiased Metagenomic Next-Generation Sequencing
por: Lee, Chun Kiat, et al.
Publicado: (2023)

Oral valganciclovir in human immunodeficiency virus-positive patients suffering from cytomegalovirus retinitis at a tertiary care hospital in North India
por: Markan, Ashish, et al.
Publicado: (2022)

Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients
por: Kim, Jong Man, et al.
Publicado: (2015)

Optimal Use of Ganciclovir and Valganciclovir in Transplanted Patients: How Does It Relate to the Outcome?
por: Mozaffar, Maryam, et al.
Publicado: (2018)

Valganciclovir—Ganciclovir Use and Systematic Therapeutic Drug Monitoring. An Invitation to Antiviral Stewardship
por: Galar, Alicia, et al.
Publicado: (2021)

Establishment and Evaluation of a Parametric Population Pharmacokinetic Model Repository for Ganciclovir and Valganciclovir
por: Yang, Wenyu, et al.
Publicado: (2023)

2715. Toxicities and clinical consequences of valganciclovir prophylaxis in solid organ transplant recipients
por: Lahoud, Chloe, et al.
Publicado: (2023)

Current Drugs to Treat Infections with Herpes Simplex Viruses-1 and -2
por: Sadowski, Lauren A., et al.
Publicado: (2021)

Neonatal Herpes Simplex Fulminant Hepatitis Successfully Treated with Acyclovir
por: Abuhasna, Said D., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5r9drl7gbm2fese6r0elbltjmf